---
schema_version: "secwatch.filing_event.v1"
accession: "0001740797-24-000049"
form_type: "8-K"
ticker: "AVAI"
cik: "0001740797"
company_name: "AVAI BIO, INC."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:32:10.131850+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Avant Technologies appoints Chris Winter as COO; receives quarterly RSA of 100,000 shares

## Summary
- Chris Winter appointed COO effective Nov 1, 2024; reports directly to the Board.
- Compensation: quarterly RSA of 100,000 shares (67,000 prorated first quarter) at 85% of 30-day VWAP, floor $0.10.
- Company pays tax gross-up bonus within 10 days of each share issuance.
- Shares fully vested upon issuance; accelerated vesting on change of control (≥50% sale).
- No relocation required; employee uses own laptop and phone.

## SEC filing metadata
- accession: 0001740797-24-000049
- form_type: 8-K
- ticker: AVAI
- cik: 0001740797
- company_name: AVAI BIO, INC.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000049/0001740797-24-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000049/form8k_avai.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001740797-24-000049
- JSON: https://secwatch.observer/filing/0001740797-24-000049.json
- Plain text: https://secwatch.observer/filing/0001740797-24-000049.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.